About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 194 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 194 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 194 trials

CompletedComparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase SchizophrenicsThe goal of this project is to show that the best possible option for preventing relapses in patients suffering from first episode (\<1 year of anti-psychotic medication) or early…NCT02360319·Tucson, Arizona and 38 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedStudy Evaluating Bifeprunox in Patients With Schizophrenia.An open-label extension study using a variable dose (20 to 30 mg daily) of bifeprunox to evaluate long-term safety.NCT00366327·Little Rock, Arkansas and 81 others

CompletedA Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With SchizophreniaThe objective of this study is to assess the safety and efficacy of 3 different doses of CTP-692 administered once daily (QD) for 12 weeks to adult participants with schizophrenia…NCT04158687·Little Rock, Arkansas and 25 others

TerminatedStudy to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaStudy to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia.NCT05182476·Phoenix, Arizona and 48 others

TerminatedA Comparison Study of LY2140023 and Aripiprazole in Schizophrenia PatientsThe purpose of this study is to determine whether weight gain will be significantly less in LY2140023 than aripiprazole in patients with schizophrenia.NCT01328093·Cerritos, California and 50 others

CompletedLong-Acting Injectable Risperidone in the Treatment of SchizophreniaIn the proposed study 450 veterans with a primary diagnosis of schizophrenia who had at least one psychiatric hospitalization for schizophrenia in the previous 2 years would be…NCT00132314·Tuscaloosa, Alabama and 18 others

CompletedAn Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With SchizophreniaThe primary objective of this study was to continue to provide aripiprazole intramuscular (IM) depot treatment (400 milligrams \[mg\] or 300 mg) to participants with schizophrenia…NCT01129882·Bellevue, California and 156 others

CompletedHomeless Youth Study - Stepping Stone 2.0Housing instability is both a cause and consequence of mental health problems.NCT03776422·Chicago, Illinois

CompletedAn Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic MedicationAn Extension study to a clinical study that will continue to evaluate the effectiveness and safety of SEP-363856 in people with schizophrenia that switch to SEP-363856 from their…NCT05741528·Anaheim, California and 15 others

CompletedA Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)This study will evaluate the safety and durability of effect of ALKS 9072 (also known as ALKS 9070) during long-term treatment of subjects with stable schizophrenia.NCT01626456·Little Rock, Arkansas and 81 others

Terminated20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative SymptomsThe purpose of this study is to evaluate the effect of AMG 747 on negative symptoms of schizophrenia in patients who are stable on current antipsychotic treatment.NCT01568216·Anaheim, California and 37 others

Recruiting52-week Open Label Safety-Tolerability StudyPhase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophreniaNCT07369154·Chandler, Arizona and 22 others

CompletedA Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic PatientsThe primary objective of this study was to assess time to discontinuation due to lack of tolerability among patients with schizophrenia receiving LY2140023, given orally twice…NCT00845026·Escondido, California and 22 others

CompletedTrial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With SchizophreniaThe purpose of this trial is to characterize the effects of 2 oral doses (over 8 weeks total) of CVL-231 on ambulatory blood pressure and heart rate in patients with stable…NCT05245539·Bentonville, Arkansas and 9 others

CompletedProof of Concept Study of Cognitive Improvement in Patients With SchizophreniaThe purpose of this study is to demonstrate that AZD3480 improves cognition in patients with stable schizophrenia who are being treated with an atypical antipsychotic and who are…NCT00528905·Little Rock, Arkansas and 79 others

CompletedStudy of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of SchizophreniaThis study evaluates the efficacy of two prescription digital therapeutics (PDT) in addition to standard of care (SOC) therapy for the treatment of experiential negative symptoms…NCT05838625·Chandler, Arizona and 53 others

RecruitingCLOZAPINE Response in Biotype-1The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention.NCT04580134·Hartford, Connecticut and 4 others

CompletedLong Term Study of RBP 7000 in the Treatment of Subjects With SchizophreniaThis is a Phase 3, open label study administering RBP-7000 in the treatment of patients with schizophrenia.NCT02203838·Little Rock, Arkansas and 47 others

RecruitingTransition Care for FEPThis study is testing a new approach to help people with first episode psychosis transition successfully from the hospital to outpatient mental health care.NCT07713849·Chicago, Illinois and 1 other

CompletedEfficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on LurasidoneThe investigators hypothesize that cognitive remediation will be superior to the active control group on the change from baseline to study end point of cognitive remediation phase…NCT01173874·Granada Hills, California and 15 others

Page 1 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia